title: Toxoplasmic encephalitis during mycophenolate mofetil immunotherapy of neuromuscular disease.
abstract: OBJECTIVE
  To show that immunotherapy with medications such mycophenolate mofetil (MMF) can cause serious complications in patients with neuromuscular disorders.
  
  
  METHODS
  Two patients with neuromuscular disorders on immunotherapy with long-term MMF who developed toxoplasmic encephalitis (TE) were included in this case series.
  
  
  RESULTS
  One patient with myasthenia gravis and one patient with inflammatory myopathy on immunotherapy with long-term MMF developed severe TE. Diagnosis was based on clinical presentation, MRI brain imaging characteristics, and CSF PCR positivity for Toxoplasma gondii. Both patients were treated with pyrimethamine, sulfadiazine, and leucovorin for 2 months without clinical improvement, and both died.
  
  
  CONCLUSIONS
  Immunotherapy with medications such as MMF can cause devastating TE in non-HIV patients with neuromuscular disorders. Early consideration and recognition of this complication is important to possibly prevent unfavorable outcomes. The utility of screening and prophylaxis against toxoplasmosis in individuals with neuroimmunologic disorders and other autoimmune disorders who receive immunosuppressive therapy requires future study.
authors: Department of Neurology, University of North Carolina School of Medicine, Chapel Hill.
authors: Danilo R
authors: DR
authors: Bernardo
authors: Department of Neurology, University of North Carolina School of Medicine, Chapel Hill.
authors: Nizar
authors: N
authors: Chahin
references: JAMA Intern Med. 2013 May 27;173(10):924-6
references: 23589123
references: Bone Marrow Transplant. 2002 Apr;29(8):691-8
references: 12180115
references: Autoimmun Rev. 2007 Jan;6(3):190-5
references: 17289556
references: N Engl J Med. 2005 Oct 6;353(14):1530-1; discussion 1530-1
references: 16207863
references: Eur J Clin Microbiol Infect Dis. 1996 May;15(5):389-93
references: 8793397
references: Rheumatology (Oxford). 2014 Feb;53(2):284
references: 24191065
references: Clin Transplant. 2000 Apr;14 (2):136-8
references: 10770418
references: Lancet. 2004 Jun 12;363(9425):1965-76
references: 15194258
references: Int J Parasitol. 2009 Oct;39(12):1385-94
references: 19433092
references: Lupus. 2005;14 Suppl 1:s2-8
references: 15803924
references: Jpn J Infect Dis. 2004 Aug;57(4):160-5
references: 15329448
references: Neurology. 2009 Oct 27;73(17):1418-9
references: 19776379
references: Transpl Int. 2011 Jan;24(1):e6-12
references: 20955469
references: Joint Bone Spine. 2010 May;77(3):246-51
references: 20451437
references: J Rheumatol. 2005 Jun;32(6):1047-52
references: 15940766
references: MMWR Recomm Rep. 2009 Apr 10;58(RR-4):1-207; quiz CE1-4
references: 19357635
references: Am J Epidemiol. 2001 Aug 15;154(4):357-65
references: 11495859
references: Mayo Clin Proc. 2013 Jan;88(1):83-105
references: 23274022
references: Clin Infect Dis. 1997 Apr;24(4):625-34
references: 9145736
references: J Rheumatol. 2010 Apr;37(4):686-8
references: 20360202